![]() ImaginAb ImaginAb clinically manages cancer and autoimmune diseases via molecular imaging by re-engineering antibodies into small proteins. | ![]() Dr Lal PathLabs Dr Lal PathLabs is an international service provider of diagnostic and related healthcare tests. | ![]() Mesoblast Mesoblast specializes in the development of biologic products for the broad field of regenerative medicine. | |
Founding Date | Founding Date 2007 | Founding Date 1949 | Founding Date 2004 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Inglewood, US HQ Bracknell, GB | Locations Gurugram, IN HQ | Locations Melbourne, AU HQ Singapore, SG New York, US |
Employees | Employees 195% decrease | Employees 4,099 | Employees 73 |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ₹27.6b (FY, 2026) | Revenue (est.) $17.2m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods ₹5.3b (FY, 2026) | Cost of goods $1.2m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit ₹23.3b (FY, 2026) | Gross profit $16.1m (FY, 2025) |
Net income | Net income N/A | Net income ₹5.1b (FY, 2026) | Net income ($102.1m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 46.8m | Total funding raised N/A | Total funding raised $ 56.2m |

Dr Lal PathLabs is an international service provider of diagnostic and related healthcare tests.
View company
Mesoblast specializes in the development of biologic products for the broad field of regenerative medicine.
View company